Tech Desk: Groundbreaking technology from PNOE is set to democratize lab-grade metabolic testing, previously confined to elite athletes and medical labs. Their new PNOE 2.0 mask enables self-serve breath analysis, allowing anyone to easily measure crucial health biomarkers like VO₂ max, resting metabolic rate, and metabolic flexibility in just eight minutes.

This innovation transforms how individuals understand their body’s energy production. By making the process self-administered, PNOE aims to expand access to fitness centers, pharmacies, and wellness programs. The device measures oxygen consumption and carbon dioxide exhalation, translating complex data into actionable advice for diet and training, directly addressing the booming longevity market.

Designed for ease and hygiene, the PNOE 2.0 features detachable components, allowing multiple users to share hardware while maintaining personal masks. Though not FDA-cleared for medical diagnosis, PNOE positions itself as a vital wellness tool, offering insights beyond what blood tests or smartwatches can provide. The company, which recently turned profitable and raised $22 million, partners with businesses like Equinox and Four Seasons to offer its “business in a box” solution.

As VO₂ max gains recognition as a strong predictor of longevity, PNOE’s accessible system offers a powerful scorecard for personal wellness. While full diagnostic capabilities are still years away, this self-serve approach marks a significant leap in personalized health monitoring, bringing sophisticated metabolic insights to the mainstream.